Status:
COMPLETED
Gut Flora Dependent Metabolism of Dietary Phosphatidylcholine and Cardiovascular Disease
Lead Sponsor:
The Cleveland Clinic
Conditions:
Nutrition
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is to see if intestinal bacteria plays a role in choline metabolism (a form of choline monitored in this study is called phosphatidylcholine, also known as lecithin). This st...
Detailed Description
The purpose of this study is to see if intestinal bacteria plays a role in choline metabolism (a form of choline monitored in this study is called phosphatidylcholine, also known as lecithin). This st...
Eligibility Criteria
Inclusion
- Men and women age 18 years or above.
- Able to provide informed consent and comply with study protocol
Exclusion
- Significant chronic illness or end-organ dysfunction, including known history of heart failure, renal failure, pulmonary disease, or hematologic diseases.
- Active infection or received antibiotics within 2 months of study enrollment
- Use of OTC probiotic within past 2 months, or ingestion of yogurt within past month
- Chronic gastrointestinal disorders, or intolerance to probiotic therapy
- Allergies to eggs.
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01519310
Start Date
April 1 2010
End Date
October 1 2014
Last Update
March 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195